Lab-Grown lymph node model reveals how CLL cells resist treatment

NCT ID NCT05610228

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study investigates how chronic lymphocytic leukemia (CLL) cells change their energy use when they are in the lymph node environment, which may help them resist standard treatments. Researchers are building a lab model using patient leukemia cells and normal lymph node cells to mimic this environment. They aim to understand why some CLL patients relapse and to test whether combining current drugs with metabolism-blocking therapies could be more effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this research could identify new drug targets for CLL patients who relapse or become resistant to current treatments.
What could go wrong
This is a small, early-stage lab study using patient cells in a dish, not a clinical treatment trial. Findings may not translate to real patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Nice University Hospital

    RECRUITING

    Nice, 06000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.